Lancap 15 Mg. Lancap 30 Mg 15 mg. 30 mg Capsules
PDF Leaflet Revision Date: 25 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of gastric and duodenal ulcers and reflux oesophagitis.
Dosage (summary)
30 mg once daily for gastric/duodenal ulcers; 15 mg for maintenance.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; safety not established.
Key Drug Interactions
- Atazanavir
- Nelfinavir
- Methotrexate
- Digoxin
Contraindications
- Hypersensitivity to lansoprazole
- Severe liver impairment
Common side effects
- Diarrhoea
- Nausea
- Headache
- Dizziness
Counselling Points
- Take before meals
- Monitor for severe diarrhoea
- Avoid alcohol
Serious warnings
- Risk of Clostridium difficile-associated diarrhoea
- Hypomagnesaemia
- Bone fractures
Important Disclaimer
The Lancap 15 Mg. Lancap 30 Mg 15 mg. 30 mg Capsules professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
